GENPHARMASEC Quarterly Results
| Consolidated | Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹40 Cr | ₹33 Cr | ₹12 Cr | ₹14 Cr | ₹8 Cr | ₹6 Cr | ₹5 Cr | ₹10 Cr |
| Expenses | ₹41 Cr | ₹33 Cr | ₹11 Cr | ₹15 Cr | ₹8 Cr | ₹6 Cr | ₹5 Cr | ₹10 Cr |
| Operating Income | ₹-1 Cr | ₹0 Cr | ₹1 Cr | ₹-1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Income | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Profit Before Tax | ₹-1 Cr | ₹-1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Profit After Tax | ₹-1 Cr | ₹-1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| EPS | ₹-0.01 | ₹-0.02 | ₹0.02 | ₹0.00 | ₹0.01 | ₹0.01 | ₹0.01 | ₹0.01 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GENPHARMASEC | 6.9% | -2.4% | -52.3% |
| SUDARSHAN CHEMICAL INDUSTRIES | 3.7% | 3.1% | -3.7% |
| KIRI INDUSTRIES | -3.8% | -5.5% | -16.2% |
| VIDHI SPECIALTY FOOD INGREDIENTS | -0.9% | -5.2% | -35.5% |
| SHREE PUSHKAR CHEMICALS & FERTILISERS | 1.1% | 4.6% | 28.4% |
| BODAL CHEMICALS | -0.7% | 2.9% | -17.1% |
| BHAGERIA INDUSTRIES | -6% | -6.1% | -20.3% |
| DYNEMIC PRODUCTS | 18.4% | 6.5% | -33.7% |
| PODDAR PIGMENTS | 2.1% | -4.4% | -27% |
GENPHARMASEC Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 22.03 % |
| Y-o-Y | 369.45 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Dec2025 | ₹40 Cr | 22.03 | |
| Sep2025 | ₹33 Cr | 171.00 | |
| Jun2025 | ₹12 Cr | -14.04 | |
| Mar2025 | ₹14 Cr | 65.13 | |
| Dec2024 | ₹8 Cr | 40.63 | |
| Sep2024 | ₹6 Cr | 16.13 | |
| Jun2024 | ₹5 Cr | -49.06 | |
| Mar2024 | ₹10 Cr | - | |
GENPHARMASEC Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Dec2025 | ₹-1 Cr | Negative | |
| Sep2025 | ₹0 Cr | Negative | |
| Jun2025 | ₹1 Cr | Positive | |
| Mar2025 | ₹-1 Cr | Negative | |
| Dec2024 | ₹1 Cr | 461.42 | |
| Sep2024 | ₹0 Cr | -28.65 | |
| Jun2024 | ₹0 Cr | Positive | |
| Mar2024 | ₹0 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2025 | -3.11% | Negative | |
| Sep2025 | -1.45% | Negative | |
| Jun2025 | 7.8% | Positive | |
| Mar2025 | -7.13% | Negative | |
| Dec2024 | 8.4% | 298.10 | |
| Sep2024 | 2.11% | -38.48 | |
| Jun2024 | 3.43% | Positive | |
| Mar2024 | -0.13% | - | |
GENPHARMASEC Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2025 | ₹-1 Cr | Negative | |
| Sep2025 | ₹-1 Cr | Negative | |
| Jun2025 | ₹1 Cr | Positive | |
| Mar2025 | ₹0 Cr | Negative | |
| Dec2024 | ₹1 Cr | 7.68 | |
| Sep2024 | ₹1 Cr | 144.95 | |
| Jun2024 | ₹0 Cr | -41.31 | |
| Mar2024 | ₹0 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2025 | -2.09 % | Negative | |
| Sep2025 | -3.6 % | Negative | |
| Jun2025 | 10.08 % | Positive | |
| Mar2025 | -1.93 % | Negative | |
| Dec2024 | 8.92 % | -23.43 | |
| Sep2024 | 11.65 % | 111.05 | |
| Jun2024 | 5.52 % | 15.24 | |
| Mar2024 | 4.79 % | - | |
GENPHARMASEC Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Dec2025 | ₹-0.01 | Negative | |
| Sep2025 | ₹-0.02 | Negative | |
| Jun2025 | ₹0.02 | 0 | |
| Mar2025 | ₹0 | -100.00 | |
| Dec2024 | ₹0.01 | 0.00 | |
| Sep2024 | ₹0.01 | 0.00 | |
| Jun2024 | ₹0.01 | 0.00 | |
| Mar2024 | ₹0.01 | - | |
You may also like the below Video Courses